Back to search

Article

Efficacy of Curcumin in Neurodegenerative Diseases: From Pharmacokinetic Barriers to Advanced Delivery Systems

2026-08-14

Abstract excerpt

<h4>Background: </h4> /Objectives: The main neurodegenerative diseases (NDs) - Alzheimer’s disease (AD), Parkinson’s disease (PD), multiple sclerosis (MS), and amyotrophic lateral sclerosis (ALS) - represent a growing global health burden with no available disease-modifying therapies. Curcumin, a polyphenol from Curcuma longa, is a promising candidate owing to its pleiotropic antioxidant, anti-inflammatory, and ne...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
11243454-03b8-5525-8f4b-4085f0c4bb55
DOI
10.20944/preprints202608.1026.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Efficacy of Curcumin in Neurodegenerative Diseases: From Pharmacokinetic Barriers to Advanced Delivery SystemsDOI 10.20944/preprints202608.1026.v1
Select a neighboring publication to make it the new centre.